GlycoMimetics Inc (NASDAQ:GLYC)

Data as of Jan 30
 +0.12 / +1.66%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

GlycoMimetics, Inc. is a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Gaithersburg, MD.

Contact Information

GlycoMimetics, Inc.
401 Professional Drive
Gaithersburg Maryland 20879
P:(240) 243-1201
Investor Relations:
(240) 243-1207



Individual stakeholders54.21%
Mutual fund holders14.35%
Other institutional12.57%

Top Executives

Rachel K. KingPresident, Chief Executive Officer & Director
Brian M. HahnChief Financial Officer & Head-Media Relations
John L. MagnaniSecretary, Director, Chief Scientific Officer & VP
Helen M. ThackrayChief Medical Officer & VP-Clinical Development
Armand GirardVice President-Corporate Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.